The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2

Volume: 76, Issue: 11, Pages: 1615 - 1618
Published: Jun 27, 2020
Abstract
SARS-CoV-2 infection has been divided by scientific opinion into three phases: the first as asymptomatic or slightly symptomatic and the second and the third with greater severity, characterized by a hyperinflammatory and fibrotic state, responsible for lung lesions, in some cases fatal. The development of antiviral drugs directed against SARS-CoV-2 and effective vaccines is progressing; meanwhile, the best pharmacological objective is related...
Paper Details
Title
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2
Published Date
Jun 27, 2020
Volume
76
Issue
11
Pages
1615 - 1618
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.